Is intraoperative remifentanil associated with acute or chronic postoperative pain after prolonged surgery? An update of the literature

Clinical Journal of Pain

Volumn 32, Issue 8, 2016, Pages 726-735

  De Hoogd, Sjoerd ^a   Ahlers, Sabine J G M ^a   Van Dongen, Eric P A ^a   Van De Garde, Ewoudt M W ^a   Hamilton Ter Brake, Tanja A T ^a   Dahan, Albert ^b   Tibboel, Dick ^d   Knibbe, Catherijne A J ^a,c,d  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

hyperalgesia; postoperative pain; remifentanil

Indexed keywords

INHALATION ANESTHETIC AGENT; REMIFENTANIL; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ANALGESIA; CHRONIC PAIN; DRUG TOLERANCE; EMBASE; HUMAN; HYPERALGESIA; INTRAVENOUS ANESTHESIA; MEDLINE; PAIN ASSESSMENT; PAIN INTENSITY; PEROPERATIVE CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; INTRAOPERATIVE CARE; PAIN, POSTOPERATIVE; PIPERIDINES;

EID: 84949009752     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0000000000000317     Document Type: Review

References (69)

1. Apfelbaum JL, Chen C, Mehta SS. et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003; 97: 534-540
2. Sommer M, De Rijke JM, van Kleef M. et al. The prevalence of postoperative pain in a sample of 1490 surgical inpatients. Eur J Anaesthesiol. 2008; 25: 267-274
3. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367: 1618-1625
4. van Gulik L, Janssen LI, Ahlers SJ. et al. Risk factors for chronic thoracic pain after cardiac surgery via sternotomy. Eur J Cardiothorac Surg. 2011; 40: 1309-1313
5. Choiniere M, Watt-Watson J, Victor JC. et al. Prevalence of and risk factors for persistent postoperative nonanginal pain after cardiac surgery: a 2-year prospective multicentre study. CMAJ. 2014; 186: E213-E223
6. Macrae WA. Chronic post-surgical pain: 10 years on. Br J Anaesth. 2008; 101: 77-86
7. Mongardon N, Pinton-Gonnet C, Szekely B. et al. Assessment of chronic pain after thoracotomy: a 1-year prevalence study. Clin J Pain. 2011; 27: 677-681
8. Goldstein E, Farquhar M, Crofton C. et al. Measuring hospital care from the patients' perspective: an overview of the CAHPS Hospital Survey development process. Health Serv Res. 2005; 40(pt 2): 1977-1995
9. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006; 104: 570-587
10. Koppert W, Schmelz M. The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract Res Clin Anaesthesiol. 2007; 21: 65-83
11. Raffa RB, Pergolizzi JV Jr. Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients?. Pain Manag Nurs. 2013; 14: e67-e83
12. Rivosecchi RM, Rice MJ, Smithburger PL. et al. An evidence based systematic review of remifentanil associated opioidinduced hyperalgesia. Expert Opin Drug Saf. 2014; 13: 587-603
13. Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-Analysis. Br J Anaesth. 2014; 112: 991-1004
14. Westmoreland CL, Hoke JF, Sebel PS. et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology. 1993; 79: 893-903
15. Thompson JP, Rowbotham DJ. Remifentanil-An opioid for the 21st century. Br J Anaesth. 1996; 76: 341-343
16. Kim SH, Stoicea N, Soghomonyan S. et al. Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review. Front Pharmacol. 2014; 5: 108
17. Guntz E, Dumont H, Roussel C. et al. Effects of remifentanil on N-methyl-D-Aspartate receptor: an electrophysiologic study in rat spinal cord. Anesthesiology. 2005; 102: 1235-1241
18. Jevtovic-Todorovic V, Todorovic SM, Mennerick S. et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998; 4: 460-463
19. Grasshoff C, Gillessen T. Effects of propofol on N-methyl-Daspartate receptor-mediated calcium increase in cultured rat cerebrocortical neurons. Eur J Anaesthesiol. 2005; 22: 467-470
20. Martucci KT, Eisenach JC, Tong C. et al. Opioid-independent mechanisms supporting offset analgesia and temporal sharpening of nociceptive information. Pain. 2012; 153: 1232-1243
21. Chu LF, Cun T, Ngai LK. et al. Modulation of remifentanilinduced postinfusion hyperalgesia by the beta-blocker propranolol in humans. Pain. 2012; 153: 974-981
22. Angst MS, Koppert W, Pahl I. et al. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003; 106: 49-57
23. Luginbuhl M, Gerber A, Schnider TW. et al. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg. 2003; 96: 726-732
24. Lenz H, Raeder J, Draegni T. et al. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans. Pain. 2011; 152: 1289-1297
25. Chu LF, Dairmont J, Zamora AK. et al. The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia. J Pain. 2011; 12: 108-115
26. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008; 24: 479-496
27. Pasero C, McCaffery M. Opioid-induced hyperalgesia. J Perianesth Nurs. 2012; 27: 46-50
28. Haroutiunian S, Nikolajsen L, Finnerup NB. et al. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain. 2013; 154: 95-102
29. Lee C, Kim YD, Kim JN. Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol. 2013; 64: 301-307
30. Lee C, Lee HW, Kim JN. Effect of oral pregabalin on opioidinduced hyperalgesia in patients undergoing laparo-endoscopic single-site urologic surgery. Korean J Anesthesiol. 2013; 64: 19-24
31. Guignard B, Bossard AE, Coste C. et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000; 93: 409-417
32. Joly V, Richebe P, Guignard B. et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 2005; 103: 147-155
33. Song YK, Lee C, Seo DH. et al. Interaction between postoperative shivering and hyperalgesia caused by high-dose remifentanil. Korean J Anesthesiol. 2014; 66: 44-51
34. Treskatsch S, Klambeck M, Mousa SA. et al. Influence of high-dose intraoperative remifentanil with or without amantadine on postoperative pain intensity and morphine consumption in major abdominal surgery patients: a randomised trial. Eur J Anaesthesiol. 2014; 31: 41-49
35. Lison S, Schill M, Conzen P. Fast-track cardiac anesthesia: efficacy and safety of remifentanil versus sufentanil. J Cardiothorac Vasc Anesth. 2007; 21: 35-40
36. Lee C, Song YK, Jeong HM. et al. The effects of magnesium sulfate infiltration on perioperative opioid consumption and opioid-induced hyperalgesia in patients undergoing robotassisted laparoscopic prostatectomy with remifentanil-based anesthesia. Korean J Anesthesiol. 2011; 61: 244-250
37. Ryu JH, Sohn IS, Do SH. Controlled hypotension for middle ear surgery: a comparison between remifentanil and magnesium sulphate. Br J Anaesth. 2009; 103: 490-495
38. Minkowitz HS. Postoperative pain management in patients undergoing major surgery after remifentanil vs. fentanyl anesthesia. Multicentre Investigator Group. Can J Anaesth. 2000; 47: 522-528
39. Fukunaga AF, Alexander GE, Stark CW. Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain. 2003; 101: 129-138
40. Lee LH, IrwinMG, Lui SK. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology. 2005; 102: 398-402
41. Derrode N, Lebrun F, Levron JC. et al. Influence of peroperative opioid on postoperative pain after major abdominal surgery: sufentanil TCI versus remifentanil TCI. A randomized, controlled study. Br J Anaesth. 2003; 91: 842-849
42. Rauf K, Vohra A, Fernandez-Jimenez P. et al. Remifentanil infusion in association with fentanyl-propofol anaesthesia in patients undergoing cardiac surgery: effects on morphine requirement and postoperative analgesia. Br J Anaesth. 2005; 95: 611-615
43. Lahtinen P, Kokki H, Hynynen M. Remifentanil infusion does not induce opioid tolerance after cardiac surgery. J Cardiothorac Vasc Anesth. 2008; 22: 225-229
44. Maddali MM, Kurian E, Fahr J. Extubation time, hemodynamic stability, and postoperative pain control in patients undergoing coronary artery bypass surgery: an evaluation of fentanyl, remifentanil, and nonsteroidal antiinflammatory drugs with propofol for perioperative and postoperative management. J Clin Anesth. 2006; 18: 605-610
45. Richebe P, Pouquet O, Jelacic S. et al. Target-controlled dosing of remifentanil during cardiac surgery reduces postoperative hyperalgesia. J Cardiothorac Vasc Anesth. 2011; 25: 917-925
46. Yeom JH, Kim KH, Chon MS. et al. Remifentanil used as adjuvant in general anesthesia for spinal fusion does not exhibit acute opioid tolerance. Korean J Anesthesiol. 2012; 63: 103-107
47. Shin SW, Cho AR, Lee HJ. et al. Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery. Br J Anaesth. 2010; 105: 661-667
48. Jo HR, Chae YK, Kim YH. et al. Remifentanil-induced pronociceptive effect and its prevention with pregabalin. Korean J Anesthesiol. 2011; 60: 198-204
49. Gaszynski TM, Strzelczyk JM, Gaszynski WP. Post-Anesthesia recovery after infusion of propofol with remifentanil or alfentanil or fentanyl in morbidly obese patients. Obes Surg. 2004; 14: 498-503. discussion 504
50. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005; 14: 798-804
51. Salengros JC, Huybrechts I, Ducart A. et al. Different anesthetic techniques associated with different incidences of chronic post-thoracotomy pain: low-dose remifentanil plus presurgical epidural analgesia is preferable to high-dose remifentanil with postsurgical epidural analgesia. J Cardiothorac Vasc Anesth. 2010; 24: 608-616
52. Van Gulik L, Ahlers SJ. Remifentanil during cardiac surgery is associated with chronic thoracic pain 1 yr after sternotomy. Br J Anaesth. 2012; 109: 616-622
53. Song JG, Shin JW, Lee EH. et al. Incidence of postthoracotomy pain: a comparison between total intravenous anaesthesia and inhalation anaesthesia. Eur J Cardiothorac Surg. 2012; 41: 1078-1082
54. Cho AR, Kwon JY, Kim KH. et al. The effects of anesthetics on chronic pain after breast cancer surgery. Anesth Analg. 2013; 116: 685-693
55. Bong CL, Samuel M, Ng JM. et al. Effects of preemptive epidural analgesia on post-thoracotomy pain. J Cardiothorac Vasc Anesth. 2005; 19: 786-793
56. Wilder-Smith OH, Arendt-Nielsen L. Postoperative hyperalgesia: its clinical importance and relevance. Anesthesiology. 2006; 104: 601-607
57. Petrenko AB, Yamakura T, Sakimura K. et al. Defining the role of NMDA receptors in anesthesia: are we there yet?. Eur J Pharmacol. 2013; 723C: 29-37
58. Echevarria G, Elgueta F, Fierro C. et al. Nitrous oxide (N(2)O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anaesthesia in humans. Br J Anaesth. 2011; 107: 959-965
59. Yuan Y, Wang JY, Yuan F. et al. Glycogen synthase kinase-3beta contributes to remifentanil-induced postoperative hyperalgesia via regulating N-methyl-D-Aspartate receptor trafficking. Anesth Analg. 2013; 116: 473-481
60. Li Y, Wang H, Xie K. et al. Inhibition of glycogen synthase kinase-3beta prevents remifentanil-induced hyperalgesia via regulating the expression and function of spinal N-methyl-Daspartate receptors in vivo and vitro. PLoS One. 2013; 8: e77790
61. Werner MU. Vanguard research in opioid-induced hyperalgesia- but guard the basics. Pain. 2012; 153: 943-944
62. Komatsu R, Turan AM, Orhan-Sungur M. et al. Remifentanil for general anaesthesia: a systematic review. Anaesthesia. 2007; 62: 1266-1280
63. Uchida K, Yasunaga H, Miyata H. et al. Impact of remifentanil introduction on practice patterns in general anesthesia. J Anesth. 2011; 25: 864-871
64. Ozkose Z, Yalcin Cok O, Tuncer B. et al. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA). J Clin Anesth. 2002; 14: 161-168
65. Alper I, Erhan E, Ugur G. et al. Remifentanil versus alfentanil in total intravenous anaesthesia for day case surgery. Eur J Anaesthesiol. 2003; 20: 61-64
66. Mukherjee K, Seavell C, Rawlings E. et al. A comparison of total intravenous with balanced anaesthesia for middle ear surgery: effects on postoperative nausea and vomiting, pain, and conditions of surgery. Anaesthesia. 2003; 58: 176-180
67. Hoogd S, Ahlers SJ, van Dongen EP. et al. deRemifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial. Trials. 2014; 15: 466-6215-15-466
68. VanDenKerkhof EG, Peters ML, Bruce J. Chronic pain after surgery: time for standardization?. A framework to establish core risk factor and outcome domains for epidemiological studies. Clin J Pain. 2013; 29: 2-8
69. Turk DC, Dworkin RH, Allen RR. et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003; 106: 337-345.